Vyant Bio, Inc.
VYNTDelisted May 4, 2023- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001349929
Vyant Bio, Inc. was delisted on May 4, 2023; its insiders filed their last Form 4 on Feb 27, 2023; 17 institutions reported holding it in 13F filings for Q1 2023, worth $136.8K in total; no superinvestor held it.
13F holders, Q3 2022
Institutional positions in Vyant Bio, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 26
- +7 vs. Q2 2022
- Shares held
- 1.70M
- +294.1K (+20.9%) vs. Q2 2022
- Total value
- $949.3K
- −$329.7K (−25.8%) vs. Q2 2022
- New holders
- 7
- 4 more added
- Sold out
- 0
- 3 more reduced
2 institutions that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VYNT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 1 | $1 |
| Q1 2023 | 17 | $136.8K |
| Q4 2022 | 17 | $222.1K |
| Q3 2022 | 26 | $949.3K |
| Q2 2022 | 21 | $1.47M |
| Q1 2022 | 23 | $2.54M |
| Q4 2021 | 27 | $3.12M |
| Q3 2021 | 23 | $5.27M |
| Q2 2021 | 29 | $8.41M |
| Q1 2021 | 18 | $2.96M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Vyant Bio, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 756,799 | $422.0K | 0.00% | 00.0% | Unchanged |
| Captrust Financial Advisors | 202,725 | $113.0K | 0.00% | +202,675+405,350.0% | Added |
| Geode Capital Management, LLC | 194,586 | $108.0K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 132,797 | $74.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 75,200 | $42.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 43,901 | $24.0K | 0.00% | 00.0% | Unchanged |
| Jackson Square Capital, LLC | 30,389 | $17.0K | 0.01% | 00.0% | Unchanged |
| US Bancorp | 24,813 | $14.0K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 20,800 | $12.0K | 0.00% | +500+2.5% | Added |
| Cambridge Investment Research Advisors, Inc. | 21,460 | $12.0K | 0.00% | +21,460 | New |
| Citadel Advisors LLC | 21,558 | $12.0K | 0.00% | +21,558 | New |
| Two Sigma Securities, LLC | 21,537 | $12.0K | 0.00% | +21,537 | New |
| Country Club Bank | 20,000 | $11.0K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 20,052 | $11.0K | 0.00% | +30.0% | Added |
| NorthRock Partners, LLC | 18,832 | $11.0K | 0.00% | 00.0% | Unchanged |
| Y-Intercept (Hong Kong) Ltd | 16,605 | $9.27K | 0.00% | +16,605 | New |
| Virtu Financial LLC | 15,818 | $9.00K | 0.00% | −9,793−38.2% | Reduced |
| UBS Group AG | 13,984 | $8.00K | 0.00% | −3,453−19.8% | Reduced |
| AE Wealth Management LLC | 13,933 | $8.00K | 0.00% | 00.0% | Unchanged |
| Carlson Capital Management | 11,800 | $7.00K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 12,646 | $7.00K | 0.00% | +12,646 | New |
| Mariner, LLC | 10,273 | $6.00K | 0.00% | +10,273 | New |
| Wells Fargo & Company | 146 | $0 | 0.00% | −33−18.4% | Reduced |
| Barclays PLC | 15 | $0 | 0.00% | 00.0% | Unchanged |
| FMR LLC | 26 | $0 | 0.00% | +5+23.8% | Added |
| Advisor Group Holdings, Inc. | 120 | $0 | 0.00% | +120 | New |
| Frontier Wealth Management LLC | – | – | – | – | Not filed |
| Taylor Wealth Management Partners | – | – | – | – | Not filed |